✦ LIBER ✦

Rituximab and lupus interstitial lung disease: friend or foe?

✍ Scribed by Petros EFTHIMIOU; Manil KUKAR; Alissa HERSH

Book ID: 118079796
Publisher: Wiley (Blackwell Publishing)
Year: 2011
Tongue: English
Weight: 67 KB
Volume: 14
Category: Article
ISSN: 1756-1841
DOI: 10.1111/j.1756-185x.2010.01592.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab-induced interstitial lung dise

Rituximab-induced interstitial lung disease

✍ Stephanie A. Wagner; Apurva C. Mehta; Damian A. Laber 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract The aim of this study is to characterize rituximab‐induced interstitial lung disease (R‐ILD). The information on all reported cases of R‐ILD was reviewed. This analysis focused on patient characteristics, underlying disease, rituximab dosing schedule, and R‐ILD characteristic‐like sympt

Statins and Renal Disease: Friend or Foe

Statins and Renal Disease: Friend or Foe?

✍ Abhishek Deshmukh; Jawahar L. Mehta 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 138 KB

Hyperadiponectinemia in alcoholic liver

Hyperadiponectinemia in alcoholic liver disease: Friend or foe?

✍ Masayuki Adachi; Hiromasa Ishii 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Rituximab in severe, treatment-refractor

Rituximab in severe, treatment-refractory interstitial lung disease

✍ Keir, Gregory J.; Maher, Toby M.; Ming, Damien; Abdullah, Reza; de Lauretis, Ang 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB

Macrophages and liposomes in inflammator

Macrophages and liposomes in inflammatory disease: Friends or foes?

✍ B.J. Crielaard; T. Lammers; M.E. Morgan; L. Chaabane; S. Carboni; B. Greco; P. Z 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 457 KB

Antiviral TRIMs: friend or foe in autoim

Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease?

✍ Jefferies, Caroline; Wynne, Claire; Higgs, Rowan 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 632 KB